Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases:: Species comparison and structural changes with substrate binding and release

被引:178
作者
Faig, M
Bianchet, MA
Talalay, P
Chen, S
Winski, S
Ross, D
Amzel, LM [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA
[2] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA
[4] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80262 USA
关键词
DT diaphorase; cancer; chemoprotection; chemotherapy;
D O I
10.1073/pnas.050585797
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
NAD(P)H/quinone acceptor oxidoreductase (QR1, NQO1, formerly DT-diaphorase; EC 1.6.99.2) protects animal cells from the deleterious and carcinogenic effects of quinones and other electrophiles. In this paper we report the apoenzyme structures of human (at 1.7-Angstrom resolution) and mouse (2.8 Angstrom) QR1 and the complex of the human enzyme with the substrate duroquinone (2.5 Angstrom) (2,3,5,6-tetramethyl-p-benzoquinone). In addition to providing a description and rationale of the structural and catalytic differences among several species, these structures reveal the changes that accompany substrate or cofactor (NAD) binding and release. Tyrosine-128 and the loop spanning residues 232-236 close the binding site, partially occupying the space left vacant by the departing molecule (substrate or cofactor). These changes highlight the exquisite control of access to the catalytic site that is required by the ping-pong mechanism in which, after reducing the flavin, NAD(P)(+) leaves the catalytic site and allows substrate to bind at the vacated position. In the human QR1-duroquinone structure one ring carbon is significantly closer to the flavin N5, suggesting a direct hydride transfer to this atom.
引用
收藏
页码:3177 / 3182
页数:6
相关论文
共 20 条
  • [1] Allen F.H., 1993, CHEM AUTOMAT NEWS, V8, P31
  • [2] BEALL HD, 1995, MOL PHARMACOL, V48, P499
  • [3] Recent developments for the efficient crystallographic refinement of macromolecular structures
    Brünger, AT
    Adams, PD
    Rice, LM
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (05) : 606 - 611
  • [4] Molecular basis of the catalytic differences among DT-diaphorase of human, rat, and mouse
    Chen, S
    Knox, R
    Wu, K
    Deng, PSK
    Zhou, DJ
    Bianchet, MA
    Amzel, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1437 - 1439
  • [5] CHEN S, 1995, MOL PHARMACOL, V47, P934
  • [6] Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: Combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling
    Chen, SA
    Wu, KB
    Zhang, D
    Sherman, M
    Knox, R
    Yang, CS
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (02) : 272 - 278
  • [7] MOUSE-LIVER NAD(P)H-QUINONE ACCEPTOR OXIDOREDUCTASE - PROTEIN-SEQUENCE ANALYSIS BY TANDEM MASS-SPECTROMETRY, CDNA CLONING, EXPRESSION IN ESCHERICHIA-COLI, AND ENZYME-ACTIVITY ANALYSIS
    CHEN, SU
    CLARKE, PE
    MARTINO, PA
    DENG, PSK
    YEH, CH
    LEE, TD
    PROCHASKA, HJ
    TALALAY, P
    [J]. PROTEIN SCIENCE, 1994, 3 (08) : 1296 - 1304
  • [8] PURIFICATION AND SOME PROPERTIES OF A HIGHLY DICUMAROL-SENSITIVE LIVER DIAPHORASE
    ERNSTER, L
    LJUNGGREN, M
    DANIELSON, L
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1960, 2 (02) : 88 - 92
  • [9] SOLUBLE DIAPHORASE IN ANIMAL TISSUES
    ERNSTER, L
    NAVAZIO, F
    [J]. ACTA CHEMICA SCANDINAVICA, 1958, 12 (03): : 595 - 595
  • [10] DT DIAPHORASE .1. PURIFICATION FROM SOLUBLE FRACTION OF RAT-LIVER CYTOPLASM, AND PROPERTIES
    ERNSTER, L
    LJUNGGREN, M
    DANIELSON, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1962, 58 (02) : 171 - +